Related Experiment Video
Updated: Jul 15, 2026

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
Published on: March 10, 2023
Ergodic Manipulation of Genome Chaos: Innovative Strategies against Malignant Progression
Sergey Shityakov1, Viacheslav Kravtsov1
1Laboratory of Chemoinformatics, Infochemistry Scientific Center, ITMO University, Lomonosova str. 9, 191002, Saint Petersburg, Russia.
Abstract:
Genome instability is a key driver of malignant progression in cancer and is characterized by chromoanagenesis, including spontaneous events, such as chromothripsis, chromoanasynthesis, and chromoplexy. These genome catastrophes create the heterogeneity necessary for tumor cells to adapt, evolve, and resist therapy. Ergodic anticancer therapy represents a novel strategy for targeting cancer stem cells by manipulating their genome chaos. Two approaches have been proposed: ergodynamic anticancer therapy (EDAT), which enhances genome chaos beyond a critical threshold and leads to self-destruction, and ergostatic anticancer therapy (ESAT), which suppresses chaos and limits malignant progression. This short communication explores the conceptual foundations, molecular mechanisms, and therapeutic potential of ergostatic and ergodynamic therapies in treating cancer, highlighting their role in personalized medicine.
Related Concept Videos
What is Genetic Engineering?
CRISPR
DNA Damage can Stall the Cell Cycle
Combinatorial Gene Control
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
Synthetic Biology
Golden rice
Golden rice is a genetically modified...
Epigenetic Regulation
X-chromosome...

